About Atrial Fibrillation

Atrial Fibrillation is the most common heart disease occurring from the heart’s atria. Read more about the symptoms, causes and treatments of the heart disease.

About the AFIP foundation

The AFIP foundation aims to stop atrial fibrillation through co-creation between researchers and patients.

“The patient with atrial fibrillation is the center of our medical universe around which all our work resolves and towards which all our efforts tend.” 

                William Murphy (1892-1987)

Support AFIP

Help us stop Atrial Fibrillation and find out why your donation is important.

Our research

Learn more about innovative studies we perform in the field of Atrial Fibrillation. 

Our partners

Browse through our partners and read about how your organization can become a partner.

AFIP updates

DnAFix project: DNA damage as a new biomarker for Atrial Fibrillation

Deel AFIP met je vrienden Facebook Twitter Google+

L-glutamine alters HSP levels and normalises energy status in patients with atrial fibrillation

Treatment strategies for atrial fibrillation (AF) are only moderately effective and do not prevent AF onset and progression. This difficulty of treatment predicts a great need to dissect root causes of AF and to develop novel therapies. Emerging research findings indicate that heat shock proteins (HSP) mitigate AF onset and progression in experimental model systems [...]

DnAFix project: Unraveling of genetic causes of atrial fibrillation, from mechanism to treatment

Younger people may experience atrial fibrillation due to a genetic cause. The German-Dutch research team has identified atrial fibrillation families that carry mutations in genes responsible for proteins of the cytoskeleton, the building blocks of heart cells.   Recently published findings from the lab of Prof. Bianca Brundel indicate that atrial fibrillation causes DNA damage [...]

Blijf op de hoogte